Abstract
The article is designed as an educational material for American family physicians and is a clear review of basic knowledge about endometrial cancers. It can be criticized for a few details, the most important of which is that there is no "new" classification of FIGO, which was known in the second half of 2009.
At present, endometrial cancer, as in the USA, is in the first place in the incidence of malignant tumors of the female reproductive organs. The incidence in our country has risen above 34 / 100,000 and we diagnose over 1,800 new diseases a year.
It is favorable that mortality is comparable to the USA and fell below 6 / 100,000. In pathogenesis, it is still true that endometrial cancers can be simply divided into type I, which is represented by the "classic" endometroid type of well-differentiated cancers.
Here, the most significant risk factor is relative or absolute hyperestrinism. The authors did not work with more recent histopathological classifications in type II and also report adenosquamous carcinoma, where today we use adenocarcinoma with a squamous component (the grading of the gland component is decisive) and subject to acceptance of the mucinous variant among "aggressive" II tumors. type.